Article info
PDFTherapeutic Intervention
Riluzole and Motor Neurone Disease
Citation
Riluzole and Motor Neurone Disease
Publication history
- First published June 1, 2003.
Online issue publication
June 01, 2003
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2003 BMJ
Other content recommended for you
- Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial)
- Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000
- Study protocol of RESCUE-ALS: A Phase 2, randomised, double-blind, placebo-controlled study in early symptomatic amyotrophic lateral sclerosis patients to assess bioenergetic catalysis with CNM-Au8 as a mechanism to slow disease progression
- The management of motor neurone disease
- Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
- Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China
- A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland
- Amyotrophic lateral sclerosis and motor neuron syndromes in Asia
- Neck weakness is a potent prognostic factor in sporadic amyotrophic lateral sclerosis patients
- Epidemiology of ALS in Korea using nationwide big data